The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile

This publication has 25 references indexed in Scilit:

• Saccharomyces boulardii Inhibits ERK1/2 Mitogen-activated Protein Kinase Activation Both in Vitro and in Vivo and Protects against Clostridium difficile Toxin A-induced Enteritis
  Journal of Biological Chemistry, 2006
• Probiotic use in clinical practice: what are the risks?
  The American Journal of Clinical Nutrition, 2006
• Analytical approach to determination of safety of milk ingredients from hyperimmunized cows
  Regulatory Toxicology and Pharmacology, 2005
• Study of Humoral Immunity to Commensal Oral Bacteria in Human Infants Demonstrates the Presence of Secretory Immunoglobulin A Antibodies Reactive with Actinomyces naeslundii Genospecies 1 and 2 Ribotypes
  Clinical and Vaccine Immunology, 2004
• Epidemiology of Clostridium difficile-associated infections
  Clinical Microbiology & Infection, 2001
• Treatment of Enterotoxigenic and EnteropathogenicEscherichia coli-induced Diarrhoea in Children with Bovine Immunoglobulin Milk Concentrate from Hyperimmunized Cows: A Double-blind, Placebo-controlled, Clinical Trial
  Scandinavian Journal of Gastroenterology, 2000
• Pathogenesis of Clostridium difficile infection
  Journal of Antimicrobial Chemotherapy, 1998
• Milk Immunoglobulin with Specific Activity against Purified Colonization Factor Antigens Can Protect against Oral Challenge with EnterotoxigenicEscherichia coli
  The Journal of Infectious Diseases, 1998
• Passive immunity against diarrhoea
  Acta Paediatrica, 1996
• Use of Bovine Milk Concentrate Containing Antibody to Rotavirus to Treat Rotavirus Gastroenteritis in Infants
  The Journal of Infectious Diseases, 1987